SeraCare Overview
- Year Founded
-
1984

- Status
-
Acquired/Merged
- Employees
-
196

- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
2
SeraCare General Information
Description
Manufacturer of biological products catering to the global life sciences and diagnostic testing industry. The company offers a wide range of diagnostic controls, plasma-derived reagents, molecular biomarkers, biobanking, molecular solutions, multiplexed, variant solutions, and contract research products and services, enabling clients to discover, develop, and provide human diagnostics and therapeutics including serology and antigen solutions.
Contact Information
Website
www.seracare.com(Operating Subsidiary)
Corporate Office
- 37 Birch Street
- Milford, MA 01757
- United States
Corporate Office
- 37 Birch Street
- Milford, MA 01757
- United States
SeraCare Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
SeraCare Comparisons
Industry
Financing
Details
SeraCare Competitors (53)
One of SeraCare’s 53 competitors is Luminex, a Corporate Backed or Acquired company based in Austin, TX.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Luminex | Corporate Backed or Acquired | Austin, TX | ||||
Oxford Gene Technology | Formerly VC-backed | Begbroke, United Kingdom | ||||
SomaGenics | Corporation | Santa Cruz, CA | ||||
Source Bioscience | Corporation | Riverstown, Ireland | ||||
Aragen Life Sciences | Private Equity-Backed | Hyderabad, India |
SeraCare Patents
SeraCare Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230407400-A1 | Methods for preparing dna reference materials and controls | Pending | 17-Nov-2016 | ||
ES-2893000-T3 | Multiplex cellular reference materials | Active | 01-Dec-2015 | ||
EP-3384053-B1 | Multiplex cellular reference materials | Active | 01-Dec-2015 | ||
EP-3384053-A1 | Multiplex cellular reference materials | Active | 01-Dec-2015 | ||
EP-3384053-A4 | Multiplex cellular reference materials | Active | 01-Dec-2015 | C12Q1/6883 |
SeraCare Signals
SeraCare Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
SeraCare Investments & Acquisitions (2)
SeraCare’s most recent deal was a Buyout/LBO with Kirkegaard & Perry Laboratories. The deal was made on 19-Aug-2013.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Kirkegaard & Perry Laboratories | 19-Aug-2013 | Buyout/LBO | Biotechnology | ||
Genomics Collaborative | 03-Jun-2004 | Merger/Acquisition | Drug Discovery |
SeraCare FAQs
-
When was SeraCare founded?
SeraCare was founded in 1984.
-
Where is SeraCare headquartered?
SeraCare is headquartered in Milford, MA.
-
What is the size of SeraCare?
SeraCare has 196 total employees.
-
What industry is SeraCare in?
SeraCare’s primary industry is Biotechnology.
-
Is SeraCare a private or public company?
SeraCare is a Private company.
-
What is SeraCare’s current revenue?
The current revenue for SeraCare is
. -
Who are SeraCare’s investors?
Five Points Capital, Kingfish Group, LGC, and Linden (Chicago) have invested in SeraCare.
-
Who are SeraCare’s competitors?
Luminex, Oxford Gene Technology, SomaGenics, Source Bioscience, and Aragen Life Sciences are some of the 53 competitors of SeraCare.
-
When was SeraCare acquired?
SeraCare was acquired on 01-Mar-2023.
-
Who acquired SeraCare?
SeraCare was acquired by American Plasma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »